Comparable stake leader
ACCESS INDUSTRIES, LLC
SEC ownership of MediWound Ltd.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001593984.
Disclosed value leader
ACCESS INDUSTRIES, LLC
Comparable rows
5/50
Latest evidence
11 Nov 2026
- Public ticker
- MDWD on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
ACCESS INDUSTRIES, LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
5 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
ACCESS INDUSTRIES, LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
11 Nov 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001593984
- Issuer location
- Yavne, Israel
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of MediWound Ltd. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ACCESS INDUSTRIES, LLC
Disclosed value leader
ACCESS INDUSTRIES, LLC
Comparable rows
5/50
Latest evidence
11 Nov 2026
13D/G
13F
3/4/5
Lead comparable stake: 12%
45 rows are not safely comparable across share classes.
13D/G row: ACCESS INDUSTRIES, LLC
Showing 1-8 of 50 holder rows.
Quick read
ACCESS INDUSTRIES, LLC leads the comparable SEC ownership view at 12%.
5 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ACCESS INDUSTRIES, LLC's linked filing trail.
Comparable ownership
Top 5
ACCESS INDUSTRIES, LLC
12%
Hold Alapkezelo Zrt.
10%
Rosalind Advisors, Inc.
9.1%
Yelin Lapidot Holdings Management...
6%
PRICE T ROWE ASSOCIATES INC /MD/
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ACCESS INDUSTRIES, LLC |
13D/G
Access Industries Holdings LLC
|
12%
Reported 13D/G
· 30 Sep 2025
|
$26,690,490
1,481,521 shares
|
$0 | 30 Sep 2025 |
| Hold Alapkezelo Zrt. |
13D/G
|
10%
Reported 13D/G
· 27 Aug 2026
|
—
1,348,323 shares
|
$0 | 27 Aug 2026 |
| Rosalind Advisors, Inc. |
13D/G
|
9.1%
Reported 13D/G
· 05 Nov 2026
|
—
1,312,319 shares
|
$0 | 05 Nov 2026 |
| Yelin Lapidot Holdings Management Ltd. |
13D/G
13F
Company
|
6%
Reported 13D/G
· 31 Dec 2025
|
$14,085,491
763,069 shares
|
$0 | 31 Dec 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
T. Rowe Price Associates, Inc.
|
5%
Reported 13D/G
· 30 Jun 2026
|
$9,430,213
641,075 shares
|
-$1,011,636 | 30 Jun 2026 |
| Silverberg Bernstein Capital Management LLC |
13F
Company
|
—
denominator unverified
|
$3,250,092
236,027 shares
|
— | 30 Sep 2026 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$2,306,792
167,523 shares
|
— | 30 Sep 2026 |
| ARK Investment Management LLC |
13F
Company
|
—
denominator unverified
|
$2,020,293
146,717 shares
|
— | 30 Sep 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$60,599.
Buys
$142,671
Insiders: 3
Sells
$82,072
Insiders: 2
Net
+$60,599
Shares: +3,864
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 10,212
Shares: 6,348
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 525 | 6,348 | $6,626 | $82,072 | -$75,447 |
| 3-6 | 9,687 | 0 | $136,046 | $0 | +$136,046 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-11 of 11 reporting-owner rows connected to MediWound Ltd.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
11
Largest Forms 3/4/5 holder
Nachum Shamir
Net 12M change
+$60.6K
Full value: +$60,600 · USD · 12-month changeLatest report
11 Nov 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Nachum Shamir | Director | $1,421,479 | +$83,996 | +6.3% | Mixed | 10 Nov 2026 |
| Ofer Gonen | Chief Executive Officer | $909,081 | Median | 11 Nov 2026 | ||
| David Morton Fox | Director | $604,549 | +$49,901 | +9% | Mixed | 10 Nov 2026 |
| Shmuel Hess | COO & Chief Commercial Officer | $229,600 | -$75,394 | -25% | Mixed | 26 Aug 2026 |
| Samuel Rubinstein | Director | $102,212 | +$2,097 | +2.1% | Mixed | 01 Sep 2026 |
| Kalfon Hana Luxenburg | Chief Financial Officer | $55,840 | Mixed | 18 Mar 2026 | ||
| Yaron Meyer | EVP, GC & Corp. Secretary | $32,282 | Mixed | 18 Mar 2026 | ||
| Ety Klinger | Chief Medical Officer | $31,410 | Mixed | 18 Mar 2026 | ||
| Yaakov Aya Ben | VP Clinical & Reg. Affairs | $31,410 | Mixed | 18 Mar 2026 | ||
| Vickie Rae Driver | Director | $13,845 | Mixed | 18 Mar 2026 | ||
| Wills Stephen T. | Director | $13,087 | Mixed | 18 Mar 2026 |
Recent insider transactions for MediWound Ltd.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Ofer Gonen | MDWD | Ordinary Shares | Exercise of in-the-money or at-the-money derivative security | 14.1% | 8,168 | 66,019 | 11 Nov 2026 | Direct | ||
| Ofer Gonen | MDWD | Series A Warrants | Exercise of in-the-money or at-the-money derivative security | -100% | -8,168 | 0 | 11 Nov 2026 | Direct | ||
| Nachum Shamir | MDWD | Ordinary Shares | Exercise of in-the-money or at-the-money derivative security | 29.3% | 16,336 | 72,151 | 10 Nov 2026 | Direct | ||
| Nachum Shamir | MDWD | Series A Warrants | Exercise of in-the-money or at-the-money derivative security | -100% | -16,336 | 0 | 10 Nov 2026 | Direct | ||
| David Morton Fox | MDWD | Ordinary Shares | Exercise of in-the-money or at-the-money derivative security | 29.3% | 6,534 | 28,817 | 10 Nov 2026 | Direct | ||
| David Morton Fox | MDWD | Series A Warrants | Exercise of in-the-money or at-the-money derivative security | -100% | -6,534 | 0 | 10 Nov 2026 | Direct | ||
| Samuel Rubinstein | MDWD | Ordinary Shares | Purchase | $6,626 | $12.62 | 525 | 525 | 01 Sep 2026 | By spouse | |
| Samuel Rubinstein | MDWD | Ordinary Shares | Sale | -100% | -$6,678 | $12.72 | -525 | 0 | 01 Sep 2026 | By spouse |
| Shmuel Hess | MDWD | Ordinary Shares | Sale | -100% | -$51,149 | $12.92 | -3,958 | 0 | 27 Aug 2026 | Direct |
| Shmuel Hess | MDWD | Stock Option (right to buy ordinary shares) | Options Exercise | -40.7% | -11,000 | 16,000 | 27 Aug 2026 | Direct | ||
| Shmuel Hess | MDWD | Ordinary Shares | Sale | -100% | -$24,245 | $13.00 | -1,865 | 0 | 26 Aug 2026 | Direct |
| Shmuel Hess | MDWD | Stock Option (right to buy ordinary shares) | Options Exercise | -15.6% | -5,000 | 27,000 | 26 Aug 2026 | Direct | ||
| Nachum Shamir | MDWD | Ordinary Shares | Purchase | 12% | $83,996 | $14.00 | 6,000 | 55,815 | 03 Jun 2026 | Direct |
| David Morton Fox | MDWD | Ordinary Shares | Purchase | 18.9% | $49,901 | $14.11 | 3,537 | 22,283 | 01 Jun 2026 | Direct |
| Samuel Rubinstein | MDWD | Ordinary Shares | Purchase | 5.28% | $2,150 | $14.33 | 150 | 2,993 | 29 May 2026 | Direct |
* marks a reported price that did not pass the local price check.